In the first quarter of 2026, the volume of cryptocurrency payments for peptides in the U.S. surged to $32 million, a 700% increase compared to the same period a year earlier. These figures come from on-chain analytics that I track as part of monitoring shadow markets. Peptides, marketed as weight loss, muscle-building, and life-extension products, are increasingly sold not through pharmacies but directly, with payments in bitcoin.

The main reason is that banks and payment systems refuse to service such sellers due to compliance risks. As a result, a significant portion of suppliers accept only cryptocurrency. For many buyers, this becomes their first experience with digital assets. For example, a 49-year-old marketing director from the U.S., seeking retatrutide (an Eli Lilly drug), found a Chinese supplier who agreed to ship 20 vials for $240. On the local market, such a purchase would cost $300 monthly. The seller accepted only cryptocurrency, forcing the buyer to purchase bitcoin for the first time.

How the Market Grew: From Underground to TikTok

Analytics reveal three growth stages. Before 2025, it was a niche "underground" market with a monthly inflow of about $200,000. Then the topic caught the attention of the Make America Healthy Again movement, coinciding with Robert F. Kennedy Jr.'s appointment as head of the U.S. Department of Health and Human Services. A direct causal link cannot be established from on-chain data, but the correlation is evident.

A sharp spike occurred in late 2025 when peptides went viral in the TikTok looksmaxxing subculture. The average monthly inflow quadrupled to $9.9 million, exceeding $10 million in peak months. According to TRM Labs, digital asset inflows into the sector reached $41.4 million in 2025, a 20% increase from the previous year. The platform's global policy director compared this growth to the early stages of shadow online markets like Silk Road.

Large Sellers Shift to Stablecoins

The market is uneven: the bulk of volume comes from a narrow group of large sellers with broad client bases. Small players use various coins, but large ones rely almost exclusively on bitcoin and stablecoins. Sellers with an average deposit of $1,000 or more predominantly use "stablecoins" — this hedges against volatility in large and cross-border purchases.

Raw Materials from China and Transition from the Drug Trade

The primary raw materials for peptides are produced in China. Over three quarters of 2025, imports from China to the U.S. doubled to over $300 million. Some suppliers have transitioned to peptides from the drug trade. For instance, Chinese company Bigreat Technology, which previously supplied fentanyl and amphetamine precursors to Russia and Kazakhstan, created a separate legal entity, Zhengzhou DEPU Technology, to sell cosmetic peptides.

My comment: The peptide market is a vivid example of how cryptocurrency becomes a tool for bypassing regulatory barriers, especially in healthcare. It resembles the early days of darknet marketplaces but with a more legitimate facade. Investors should note that such niches can grow rapidly but carry high regulatory risks.